Hepatobiliary Disease Hospital of Jilin Province, Jilin, China Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01488526
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hepatology hospital of Jilin Province

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Infections (Phase 4)

Viremia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 8